Abstract. Nano-hydroxyapatite (n-HA)/chitosan (CS)/konjac glucomannan (KGM) composite was prepared by integrating composition and molding. Then, X-ray diffraction (XRD) and scanning electron microscopy (SEM) were used to analyze the physical, chemical and degradable properties of the composite before and after in simulated body fluid (SBF). Moreover, study in vitro test for drug delivery revealed that the amount of released pentoxifylline (1-[5-oxohexyl]-3,7-dimethylxanthine)(PTX) reached a plateau and equaled 80% of the drug loaded in an implant. The newly develop n-HA/CS/KGM composite may serve as a good degradable biomaterial for implantable drug delivery system (IDDS) in bone tissue engineering.
Introduction
Inorganic material has been widely used as biomaterial. Especially n-HA, this material is known for its good biocompatibility and bioactive bone behavior [1] . Recently, more attention has been paid to biodegradable biomaterials. IDDS is an example of biodegradable biomaterial available for therapeutic use. The major advantages of this system include targeted local delivery of drug, less drug required to teat the disease state, minimization of possible side effects, enhanced efficacy of treatment, and without second surge of remove the implant [2] . KGM is a neutral polysaccharide isolated from the tubers of Amorphophallus konjac C. Koch, degraded by glycolysis [3] . Besides, CS derived from the natural polymer chitin, is a biodegradable cationic polysaccharide comprised of glucosamine residues. It is known to accelerate wound healing, bone formation and drug delivery [4] . This paper was to investigate n-HA/CS/KGM composite as an IDDS: firstly, preparing of this composite; then, in vitro study on the physicochemical and degradable behaviors of n-HA/CS/KGM composite; furthermore, investigating the profile of PTX releasing in vitro from this composite.
Materials and methods
Firstly, ZnO-bearing n-HA composite powders were prepared by our laboratory and dissolved into ethanol solution, noted as A solution. Secondly, CS (80% deacetylation and average molecular weight of 250,000) powders were dissolved into 3wt% acetic acid solution with stirring for 4 hours to get a transparent solution, noted as B solution. Then, B solution was slowly dropped into A solution with vigorous stirring by weight ratio of 14:1 for n-HA/CS. The speed of dropping was around 4ml/min and the rotational speed of the stirrer was adjusted to 1000rpm. The reaction environment was carried out at room temperature. After titration, the stirring was kept for 8 hours, and then the obtained slurry was aged for another 24 hours. Then, the precipitate was filtered and washed with deionized water, and dried in a vacuum oven at 60°C. Secondly, n-HA/CS composite powders were mixed with KGM (average molecular weight of 400,000) powders according to the weight ratio of 5:1. Sequently, the powders mixed with special fixing fluid solution at P/L(powder/liquid) ratio of 1.5g/ml, and cast in mould into columnar shape (Ф12.6mmx4.0mm), compressed under 5Mpa for 30s, and heated at 60°C.
The crystallographic structure of composite powders was determined by X-ray diffraction (XRD) using a Philips X' Pert MPD diffractometer using a Cu Kα-radiation. The surface topology of the composite was examined using scanning electron microscopy (SEM, Hitachi S-450).
The SBF was prepared by dissolving reagent chemicals in the order of NaCl, NaHCO 3 , KCl, K 2 HPO 4 ·3H 2 O, MgCl 2 ·6H 2 O, CaCl 2 ·2H 2 O, and Na 2 SO 4 into deionized water [5] . All specimens were immersed in 6ml SBF for 4 and 12 weeks. All the test tubes were placed into a water bath with a constant temperature (37°C). At the end of this experiment, composites were retrieved out of the SBF solution. After rinsing in aqua and drying at room temperature, the specimens were characterized by XRD and SEM.
The implants were filled with 3mg of PTX each. The implants were introduced into 10ml of phosphatebuffer dissolution medium at pH=7.35, in round-bottomed flasks which were placed in a water bath (Elpan357) maintained at 37°C and shaken at 50 strokes/minute. In the course of the release test, samples were withdrawn by a pipette at suitable intervals. PTX concentrations in the collected samples were measured spectrophotometrically (DU-70 Spectrophotometer, Beckman) at a wavelength of 274nm. The data represented the average of two measurements from independent experiments. Fig.1 describes the XRD patterns of the composite before and after incubation in SBF. Unsoaked composites (shown in Fig.1a) shows a crystalline apatite structure with reflections (002), (211), (112), (202), respectively appeared at 25.9°, 31.9°, 32.4°and 34.1°, comparative with the XRD pattern of HA powder (JCPDS #09-0432). While the reflection peaks was seen at 34.13°, 38.48° 47.68°and 56.70°in 2-Theta corresponding to ZnO (JCPDS #36-1451) (100) (002) (102) and (110) planes. This paper employs the method of CPC self-setting, which consists of three phases composition, molding and drug loading simultaneously in one procedure. ZnO-bearing n-HA composite incorporates into CS solution. Hydrogen bonding and coordination bonding are formed between each other. In addition, KGM introduced into the two phases, new hydrogen bonding formed between CS and KGM, which results in the relative degrees of the polymer (10°and 20°) almost can't be detected in the composite. This attributes to the hydrogen bonding formed between CS and KGM. The XRD evaluation also confirms that the 12 week incubation of composite in SBF resulted in increasing peaks around 25.9°, 31-33°, indicating apatite formation during the soaking periods. According to Scherrer formulation [6] , it can be got the value of D (002) is 58.32nm and 64.12nm at 4w and 12w, respectively. It can be found that soaking time was critical toward obtaining well-crystallized HA particles with uniform morphologies. When occluded impurities are removed and crystal strain is reduced during the soaking time, whereas HA grains redissolve and are re-crystallized into more ordered forms.
Results and discussion
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Eco-Materials Processing and Design IX SEM examination of the composite surface shows the morphologies before and after incubation in SBF. It can be seen from Fig. 2A and 2a that the pre-immersed specimen has a smooth and comparatively dense surface, in which n-HA particles intimately associated with the organic matrix. With the incubation time, it can be seen that many tiny apatite precipitated on the surface, especially around the pores. Even some pores were filled with apatite particles and more pores appear on the surface (seen in Fig.2B and 2b ). Up to 12-week soaking, apatite precipitates pile up on the surface in a direction and cover some of these pores. On the other hand, the degradation of CS and KGM make more n-HA particles expose out and thus induce more apatite crystals to deposit. Therefore, the intensity of diffraction peaks for n-HA was strengthened. Besides, compared Fig.2C with Fig.2c , it can be found that the crystallized apatite is more order form than others, which is same as the XRD conclusion.
Local delivery application is one way of targeting a drug to a desired site. In bone tissue, sustained drug release can be achieved using hydroxyapatite implants loaded with given drug. In past, porous hydroxyapatite implants have been evaluated for IDDS. The amount of released drug reached 80% below 40h [7, 8] . While in this n-HA/CS/KGM system, the curve which described the amount of released PTX over time had a typically sigmoid-like pattern with a lag time of approximately 3h. After 60h, the amount of released PTX reached a plateau and almost equaled 80% of the total amount of drug loaded in an implant as shown in Fig.3 . In this n-HA/CS/KGM system, the role of carrier is fulfilled by n-HA and CS-KGM polymer. With the polymer degradation, the pores increase on the surface with time, which induces the rate of drug release improved. But the surface of implants also changes due to the precipitation-dissolution mechanism. The size and structure of pores become smaller and denser, which induces the rate of drug release is slower. After 60d, the rate is appearally decreased, compared with the other periods. Materials Science Forum Vol. 569 359 Fig.3 The cumulative PTX delivery from the n-HA/CS/KGM composite implant with the time.
Conclusion
The n-HA/CS/KGM composite was successfully prepared by integrating composition and molding. n-HA particles homogeninally disperse in the organic matrix. With the incubation time in SBF, some new pores appeared and many apatite particles deposited on the surface. Study in vitro test for drug delivery revealed that the amount of released PTX reached a plateau and up to 80% after 60d. Therefore, the developed composites have great potential to be used as degradable biomaterial for IDDS.
